Cargando…
Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis
OBJECTIVE: This study aimed to evaluate retrospectively the outcomes of Abobotulinumtoxin-A (Dysport®) intravesical injection in refractory interstitial cystitis/bladder pain syndrome patients to first- and second-line treatment. MATERIALS AND METHODS: From March 2016 to 2021, 44 adult patients with...
Autores principales: | Rahnama’i, Mohammad-Sajjad, Salehi-Pourmehr, Hanieh, Saeedi, Sana, Tayebi, Sona, Hajebrahimi, Sakineh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Association of Urology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346116/ https://www.ncbi.nlm.nih.gov/pubmed/37877871 http://dx.doi.org/10.5152/tud.2023.22243 |
Ejemplares similares
-
Translation and validation of the Persian ICIQ bladder diary
por: Tayebi, Sona, et al.
Publicado: (2021) -
Microbiome in Lower Urinary Tract Symptoms (LUTSs): Mapping the State of the Art with Bibliometric Analysis
por: Mostafaei, Hadi, et al.
Publicado: (2023) -
Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai – India
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2020) -
Underactive and low compliance bladder: A possible Presentation of COVID-19 vaccination
por: Salehi-Pourmehr, Hanieh, et al.
Publicado: (2022) -
Review of intravesical therapies for bladder pain syndrome/interstitial cystitis
por: Cvach, Kristina, et al.
Publicado: (2015)